Back to top
Prof Frank Behrens

Prof Frank Behrens

Professor of Translational Rheumatology, Immunology and Inflammation Medicine

Professor Frank Behrens is Professor of Translational Rheumatology, Immunology and Inflammation Medicine and Head of the Inflammation Clinic, University Hospital, Frankfurt am Main, Germany, and Deputy Director, Fraunhofer Institute for Translational Medicine & Pharmacology (ITMP), Goethe University, Frankfurt am Main. He is also a member of the board of directors of the Fraunhofer Cluster of Excellence for Immune-Mediated Disease (CIMD).

 

Professor Behrens studied biology at the Johannes Gutenberg University in Mainz, Germany, before going on to study human medicine. He completed his doctorate in haematology and oncology before training in internal medicine and rheumatology.

 

Professor Behrens' main research interest is the pathophysiological understanding of spondyloarthritis, rheumatoid arthritis and mixed connected tissue disease. The focus is on understanding the links between these rheumatic conditions and associated skin and bowel diseases. The aim of the work is to develop new drug therapies and implement personalised treatment approaches using combined biomarker analyses and new imaging techniques. Since 2001, he has gained experience in clinical research and development as Principal Investigator, Chief Investigator and Managing Investigator. He is responsible for several investigator-initiated studies in rheumatic diseases.

 

Professor Behrens has published numerous articles in peer-reviewed journals and is author of several textbooks in the field of rheumatic diseases.

 

Professor Behrens is a member of various international committees and study groups such as the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Expert Panel Measures in Pulmonary Arterial Hypertension Related to Outcome of Systemic Sclerosis (EPOSS) and the Psoriatic Arthritis Genetic European Consortium (PAGE).

0 resources
You are currently seeing only Dermatology content
Image
Hidracensus 7.3 HS webinar 2 bitesize 2_AFD
Video7:09 min
Exploring how the guidelines defines holistic care

Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making

GL-DC-2500038
Image
Hidracensus 7.3 HS webinar 2 bitesize 1_AFD
Video6:56 min
Personalising the approach to HS care

Personalised HS care: Addressing the multi-faceted burden of HS with a case study example

GL-DC-2500037
Image
Hidracensus 7.3 HS webinar 1 bitesize 2_AFD
Video6:54 min
Combination approaches in HS

The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention

GL-DC-2500036
Image
Hidracensus 7.3 HS webinar 1 bitesize 1_AFD
Video6:11 min
An overview of the European S2k guidelines

Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes

GL-DC-2500035
Image
UCB Hidracensus 7.3 HS Awareness Week WEBINAR_2
Video36:29 min
Shared decisions: Redefining HS treatment

Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care

EU-DC-2500055
Image
UCB Hidracensus 7.3 HS Awareness Week WEBINAR_1
Video36:53 min
From guidelines to action: Transforming HS treatment pathways

Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches

EU-BK-2500174